|
0
|
|
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial.
(linkinghub.elsevier.com)
|
Yan H
…
Zhang Y
Cell Reports Medicine
2026-06-30
|
#nsclc
#brain-metastases
#egfr-mutation
#clinical trial
#targeted therapy
|
|
0
|
|
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial.
(linkinghub.elsevier.com)
|
Rouphael N
…
Frenck RW Jr
Lancet Infectious Diseases
2026-06-30
|
#vaccination
#shigellosis
#clinical trial
#live-attenuated
#immunogenicity
|
|
0
|
|
Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.
(nature.com)
|
Gomez S
…
Hwang EI
Nature Medicine
2026-06-30
|
#immunotherapy
#t cell
#glioma
#clinical trial
#pediatric
|
|
0
|
|
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Pan HX
…
Xia NS
Lancet Infectious Diseases
2026-06-30
|
#vaccination
#immunogenicity
#hpv
#clinical trial
#cervical cancer
|